UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS 2024 FIRST QUARTER FINANCIAL RESULTS
04/24/2024
Consolidated Results of Operations - Three-Month Periods Ended
The increase in our net income of
As calculated on the attached Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our funds from operations ("FFO") were
Dividend Information:
The first quarter dividend of
Capital Resources Information:
At
In March, 2023, construction was substantially completed on the Sierra Medical
Demolition of the former specialty hospital located in
Operating expenses incurred by us in connection with the above two properties, as well as a vacant specialty facility located in
We continue to market the two remaining above-mentioned vacant properties to third parties. Future operating expenses related to these properties, will be incurred by us during the time they remain owned and unleased.
General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:
This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, as well as the operations and financial results of each of our tenants, those related to healthcare industry trends and those detailed in our filings with the
Many of the factors that could affect our future results are beyond our control or ability to predict. Future operations and financial results of our tenants, and in turn ours, could be materially impacted by various developments including, but not limited to, decreases in staffing availability and related increases to wage expense experienced by our tenants resulting from the nationwide shortage of nurses and other clinical staff and support personnel, the impact of government and administrative regulation of the health care industry; declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of business closings and layoffs); potential disruptions related to supplies required for our tenants' employees and patients; and potential increases to other expenditures.
In addition, the increase in interest rates has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms. Additional increases in interest rates could have a significant unfavorable impact on our future results of operations and the resulting effect on the capital markets could adversely affect our ability to carry out our strategy.
We believe that, if and when applicable, adjusted net income and adjusted net income per diluted share (as reflected on the Supplemental Schedule), which are non-GAAP financial measures ("GAAP" is Generally Accepted Accounting Principles in
Funds from operations ("FFO") is a widely recognized measure of performance for Real Estate Investment Trusts ("REITs"). We believe that FFO and FFO per diluted share, which are non-GAAP financial measures, are helpful to our investors as measures of our operating performance. We compute FFO, as reflected on the attached Supplemental Schedules, in accordance with standards established by the
To obtain a complete understanding of our financial performance these measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the
Consolidated Statements of Income For the Three Months Ended (amounts in thousands, except share information) (unaudited) |
||||||||
Three Months Ended |
||||||||
|
||||||||
2024 |
2023 |
|||||||
Revenues: |
||||||||
Lease revenue - UHS facilities (a.) |
$ |
8,664 |
$ |
7,787 |
||||
Lease revenue - Non-related parties |
14,487 |
13,361 |
||||||
Other revenue - UHS facilities |
220 |
231 |
||||||
Other revenue - Non-related parties |
409 |
481 |
||||||
Interest income on financing leases - UHS facilities |
1,361 |
1,366 |
||||||
25,141 |
23,226 |
|||||||
Expenses: |
||||||||
Depreciation and amortization |
6,809 |
6,618 |
||||||
Advisory fees to UHS |
1,338 |
1,302 |
||||||
Other operating expenses |
7,531 |
7,521 |
||||||
15,678 |
15,441 |
|||||||
Income before equity in income of unconsolidated limited liability companies ("LLCs") and interest expense |
9,463 |
7,785 |
||||||
Equity in income of unconsolidated LLCs |
384 |
371 |
||||||
Interest expense, net |
(4,547) |
(3,697) |
||||||
Net income |
$ |
5,300 |
$ |
4,459 |
||||
Basic earnings per share |
$ |
0.38 |
$ |
0.32 |
||||
Diluted earnings per share |
$ |
0.38 |
$ |
0.32 |
||||
Weighted average number of shares outstanding - Basic |
13,792 |
13,778 |
||||||
Weighted average number of shares outstanding - Diluted |
13,824 |
13,803 |
(a.) Includes bonus rental on |
Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule") For the Three Months Ended (amounts in thousands, except share information) (unaudited) |
||||||||||||||||
Calculation of Adjusted Net Income |
||||||||||||||||
Three Months Ended |
Three Months Ended |
|||||||||||||||
|
|
|||||||||||||||
Amount |
Per |
Amount |
Per |
|||||||||||||
Net income |
$ |
5,300 |
$ |
0.38 |
$ |
4,459 |
$ |
0.32 |
||||||||
Adjustments |
- |
- |
- |
- |
||||||||||||
Subtotal adjustments to net income |
- |
- |
- |
- |
||||||||||||
Adjusted net income |
$ |
5,300 |
$ |
0.38 |
$ |
4,459 |
$ |
0.32 |
||||||||
Calculation of Funds From Operations ("FFO") |
||||||||||||||||
Three Months Ended |
Three Months Ended |
|||||||||||||||
|
|
|||||||||||||||
Amount |
Per |
Amount |
Per |
|||||||||||||
Net income |
$ |
5,300 |
$ |
0.38 |
$ |
4,459 |
$ |
0.32 |
||||||||
Plus: Depreciation and amortization expense: |
||||||||||||||||
Consolidated investments |
6,809 |
0.50 |
6,618 |
0.48 |
||||||||||||
Unconsolidated affiliates |
304 |
0.02 |
293 |
0.02 |
||||||||||||
FFO |
$ |
12,413 |
$ |
0.90 |
$ |
11,370 |
$ |
0.82 |
||||||||
Dividend paid per share |
$ |
0.725 |
$ |
0.715 |
Consolidated Balance Sheets (amounts in thousands, except share information) (unaudited) |
||||||||
|
|
|||||||
2024 |
2023 |
|||||||
Assets: |
||||||||
Real Estate Investments: |
||||||||
Buildings and improvements and construction in progress |
$ |
650,622 |
$ |
649,374 |
||||
Accumulated depreciation |
(268,544) |
(262,449) |
||||||
382,078 |
386,925 |
|||||||
Land |
56,870 |
56,870 |
||||||
Net Real Estate Investments |
438,948 |
443,795 |
||||||
Financing receivable from UHS |
83,162 |
83,279 |
||||||
Net Real Estate Investments and Financing receivable |
522,110 |
527,074 |
||||||
Investments in and advances to limited liability companies ("LLCs") |
14,632 |
9,102 |
||||||
Other Assets: |
||||||||
Cash and cash equivalents |
7,697 |
8,212 |
||||||
Lease and other receivables from UHS |
6,645 |
6,180 |
||||||
Lease receivable - other |
8,219 |
8,166 |
||||||
Intangible assets (net of accumulated amortization of |
8,653 |
9,110 |
||||||
Right-of-use land assets, net |
10,939 |
10,946 |
||||||
Deferred charges, notes receivable and other assets, net |
17,294 |
17,579 |
||||||
Total Assets |
$ |
596,189 |
$ |
596,369 |
||||
Liabilities: |
||||||||
Line of credit borrowings |
$ |
333,650 |
$ |
326,600 |
||||
Mortgage notes payable, non-recourse to us, net |
32,506 |
32,863 |
||||||
Accrued interest |
1,088 |
490 |
||||||
Accrued expenses and other liabilities |
10,189 |
13,500 |
||||||
Ground lease liabilities, net |
10,939 |
10,946 |
||||||
Tenant reserves, deposits and deferred and prepaid rents |
11,359 |
11,036 |
||||||
Total Liabilities |
399,731 |
395,435 |
||||||
Equity: |
||||||||
Preferred shares of beneficial interest, |
- |
- |
||||||
Common shares, |
138 |
138 |
||||||
Capital in excess of par value |
270,454 |
270,398 |
||||||
Cumulative net income |
831,361 |
826,061 |
||||||
Cumulative dividends |
(912,998) |
(902,975) |
||||||
Accumulated other comprehensive income |
7,503 |
7,312 |
||||||
Total Equity |
196,458 |
200,934 |
||||||
Total Liabilities and Equity |
$ |
596,189 |
$ |
596,369 |
View original content:https://www.prnewswire.com/news-releases/universal-health-realty-income-trust-reports-2024-first-quarter-financial-results-302126566.html
SOURCE
Charles Boyle, Chief Financial Officer, (610) 768-3300